Drug intelligence / Profile preview

LIPOMUST MAX SUSP

Development stage: Preclinical
Lead developer: Intra Life
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration: Oral

Overview

LIPOMUST MAX SUSP is a liposomal oral suspension developed by Intra Life for the management of iron deficiency anemia. It contains a combination of liposomal iron, folic acid, and Vitamin B12. The liposomal delivery system is designed to enhance the bioavailability of iron while minimizing common gastrointestinal side effects such as metallic taste and gastric irritation. Iron is a critical component of hemoglobin, necessary for oxygen transport, while folic acid and Vitamin B12 serve as essential cofactors for erythropoiesis and DNA synthesis, supporting the production and maturation of healthy red blood cells.

Brand names: LIPOMUST MAX SUSP
Other names: Lipomust MaxLiposomal iron + folic acid + Vitamin B12

Targets

MTR (Methionine synthase)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on LIPOMUST MAX SUSP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIPOMUST MAX SUSP.

Explore the full profile